Health ministry decides against including Itolizumab in clinical management protocols for COVID-19

Health ministry decides against including Itolizumab in clinical management protocols for COVID-19 The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute Respiratory Distress Syndrome patients due to COVID-19. https://ift.tt/eA8V8J